UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

British journal of cancer, 2024-09, Vol.131 (5), p.955-955

2024

Volltextzugriff (PDF)

RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor

The Journal of pathology, 2008-05, Vol.215 (1), p.67-77

2008

Volltextzugriff (PDF)

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer

The Journal of pathology, 2007-09, Vol.213 (1), p.82-90

2007

Volltextzugriff (PDF)

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

British journal of cancer, 2001-12, Vol.85 (12), p.1928-1936

2001

Volltextzugriff (PDF)

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

British journal of cancer, 2005-01, Vol.92 (2), p.320-327

2005

Volltextzugriff (PDF)

Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer

Annals of surgical oncology, 2015-11, Vol.22 (12), p.3970-3975

2015

Volltextzugriff (PDF)

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

Oncogene, 2003-03, Vol.22 (9), p.1381-1389

2003

Volltextzugriff (PDF)

Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer

Oncogene, 2008-05, Vol.27 (21), p.2978-2988

2008

Volltextzugriff (PDF)

Androgen-related expression of G-proteins in ovarian cancer

British journal of cancer, 2009-07, Vol.101 (3), p.498-503

2009

Volltextzugriff (PDF)

Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer

British journal of cancer, 2013-08, Vol.109 (4), p.950-956

2013

Volltextzugriff (PDF)

Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer

Journal of cancer research and clinical oncology, 2011-02, Vol.137 (2), p.235-241

2011

Volltextzugriff (PDF)

The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance

Oncogene, 2019-05, Vol.38 (22), p.4412-4424

2019

Volltextzugriff (PDF)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype

The Journal of pathology, 2008-02, Vol.214 (3), p.394-404

2008

Volltextzugriff (PDF)

Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer

Oncogene, 2007-12, Vol.26 (55), p.7611-7619

2007

Volltextzugriff (PDF)

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease

British journal of cancer, 2009-12, Vol.101 (11), p.1891-1899

2009

Volltextzugriff (PDF)

FGF8 isoform b expression in human prostate cancer

British journal of cancer, 2003-05, Vol.88 (9), p.1432-1438

2003

Volltextzugriff (PDF)

Fibroblast growth factor 17 is over-expressed in human prostate cancer

The Journal of pathology, 2004-12, Vol.204 (5), p.578-586

2004

Volltextzugriff (PDF)

Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer

Human pathology, 2008-08, Vol.39 (8), p.1197-1204

2008

Volltextzugriff (PDF)

Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer

The Journal of pathology, 2005-06, Vol.206 (2), p.205-213

2005

Volltextzugriff (PDF)

Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding

Molecular and Cellular Biology, 1993-09, Vol.13 (9), p.5370-5376

1993

Volltextzugriff (PDF)

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies

British journal of cancer, 1998-11, Vol.78 (9), p.1219-1223

1998

Volltextzugriff (PDF)

Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

British journal of cancer, 2010-01, Vol.102 (2), p.342-350

2010

Volltextzugriff (PDF)

Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance

Oncogene, 2019-05, Vol.38 (22), p.4425-4425

2019

Volltextzugriff (PDF)

Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Coincides with the Loss of Androgen Sensitivity in Hormone Refractory Cancer of the Prostate

European urology, 2004-03, Vol.45 (3), p.382-389

2004

Volltextzugriff (PDF)

Expression of GnRH type II is regulated by the androgen receptor in prostate cancer

Endocrine-related cancer, 2007-09, Vol.14 (3), p.613-624

2007

Volltextzugriff (PDF)

1 – 25 von 1.291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.114)
Mit Volltextzugriff
(1.075)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(771)
Life Sciences & Biomedicine
(600)
Humans
(455)
Biological And Medical Sciences
(279)
Female
(262)
Male
(230)
Medical Sciences
(200)
Animals
(170)
Adult
(145)
Physical Sciences
(129)
Middle Aged
(117)
Oncology
(110)
Fundamental And Applied Biological Sciences. Psychology
(98)
Aged
(83)
Biochemistry & Molecular Biology
(74)
Pregnancy
(73)
Technology
(73)
Physics
(71)
Mice
(65)
Surgery
(62)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(608)
MEDLINE
(586)
IngentaConnect
(506)
Journals@Ovid Full Text
(479)
NUS Single-Journal Subscriptions
(235)
Elsevier ScienceDirect Journals
(220)
IngentaConnect Journals
(198)
Wiley Online Library
(191)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(135)
Wiley Online Library
(133)
SpringerLink
(107)
Oxford journals
(101)
JSTOR
(67)
IEEE Electronic Library (IEL)
(65)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(61)
Nature
(60)
Oxford Journals 2020 Medicine
(57)
Nexis Uni
(43)
Taylor & Francis
(37)
Taylor & Francis Journals Complete
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer

Androgen-related expression of G-proteins in ovarian cancer

Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer

Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer

The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype

Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease

FGF8 isoform b expression in human prostate cancer

Fibroblast growth factor 17 is over-expressed in human prostate cancer

Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer

Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer

Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies

Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance

Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Coincides with the Loss of Androgen Sensitivity in Hormone Refractory Cancer of the Prostate

Expression of GnRH type II is regulated by the androgen receptor in prostate cancer

Suchergebnisse filtern